Traton Shares Jump After VW Signals Readiness to Sell Stock, Raise Free Float
By David Sachs
Traton shares jumped Thursday after parent company Volkswagen said it is prepared to sell shares and free up more stock for investors.
At 0906 GMT, shares in the German truck-and-bus maker were up 4.8% at EUR32.50 after rising as high as EUR32.55.
Volkswagen Chief Executive Oliver Blume said Wednesday that the company is prepared to increase the number of Traton shares available to traders, acknowledging that the 10.28% free float has hindered investors. The move would make Traton stock a better prospect for investors and increase the company's chances of making the MDAX index, Blume said, speaking at Volkswagen's annual general meeting.
Volkswagen, which owns 89.72% of shares in the commercial vehicle maker, previously said its medium-term goal was to own slightly more than 75% of shares. Traton stock has soared 52% since the year began.
Traton, which went public in 2019, includes the MAN, Scania, Navistar, and Volkswagen Truck & Bus brands.
Write to David Sachs at david.sachs@wsj.com
(END) Dow Jones Newswires
May 30, 2024 05:27 ET (09:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks